Copertina

Critique on “Evaluation of the Presence of Native Valvular Disease in Patients With Atrial Fibrillation Using the EHRA (Evaluated Heartvalves, Rheumatic, or Artificial) Classification”

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Arooha Javed, Syed Muhammad Savez, Syed Muhammad Rayyan
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Clinical Cardiology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Evaluation of the Presence of Native Valvular Disease in Patients With Atrial Fibrillation Using the EHRA (Evaluated Heartvalves, Rheumatic, or Artificial) Classification
di: Antonio Escolar Conesa, et al.
Pubblicazione: (2025)

Methodological Considerations in Evaluating CTRP12 as a Biomarker for In‐Stent Restenosis
di: Saleha Khattak, et al.
Pubblicazione: (2026)

Advancing Equity in Left Atrial Appendage Occlusion Outcomes for Hispanic/Latino Patients
di: Syed Muhammad Rayyan, et al.
Pubblicazione: (2025)

Case Ascertainment and Exposure Classification in Acute Myocardial Infarction Mortality Studies Involving Psychoactive Substance Use
di: Noor‐ul‐Eman Haider, et al.
Pubblicazione: (2025)

Methodological Considerations in Assessing HALP Score as a Prognostic Marker in Rheumatic Mitral Stenosis
di: Muhammad Talha, et al.
Pubblicazione: (2026)

Generalizability of Low‐Voltage Zone‐Based Risk Scores After Atrial Fibrillation Ablation
di: Laiba Anwar, et al.
Pubblicazione: (2026)

Trends in Chronic Ischemic Heart Disease‐Related Mortality in Older Adults With Atrial Fibrillation (1999–2023): A CDC WONDER Database Analysis
di: Muhammad Shaheer Bin Faheem, et al.
Pubblicazione: (2026)

Safety and Efficacy of Direct Oral Anticoagulants Versus Vitamin K Antagonists for Cerebrovascular Ischemic Outcomes in Non‐Valvular Atrial Fibrillation: A Systematic Review and Meta‐Analysis
di: Anam Nasir, et al.
Pubblicazione: (2026)

Association Between Changes in Heart Rate and Adverse Events in Patients With Non‐Valvular Atrial Fibrillation: A Post Hoc Analysis of the J‐RHYTHM Registry
di: Eitaro Kodani, et al.
Pubblicazione: (2025)

Reconsidering the Prognostic Role of the HALP Score in Rheumatic Mitral Stenosis
di: Muhammad Talha, et al.
Pubblicazione: (2026)

Methodological Concerns Regarding a Recent Meta‐Analysis of Direct Oral Anticoagulants Versus Vitamin K Antagonists in Non‐Valvular Atrial Fibrillation
di: Omar Khalid Samir, et al.
Pubblicazione: (2026)

Clinical Characteristics and Outcomes of Catheter Ablation in Young Patients With Atrial Fibrillation
di: Xuewen Wang, et al.
Pubblicazione: (2025)

How to Assess the Functional Impact of Atrial Fibrillation in Patients With Heart Failure
di: Naoya Kataoka, et al.
Pubblicazione: (2025)

Evaluating the Impact of Catheter Ablation on Cardiovascular and Cerebral Outcomes in Atrial Fibrillation With Heart Failure and Preserved Ejection Fraction
di: Wei‐Chieh Lee, et al.
Pubblicazione: (2025)

Meta‐Analysis Comparing Oral Anticoagulant Monotherapy Versus Dual Antithrombotic Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease
di: Mushood Ahmed, et al.
Pubblicazione: (2024)

A Valuable Contribution to Atrial Fibrillation Ablation in Young Adults: The Role of Long‐Term Follow‐Up and Silent Atrial Fibrillation Monitoring
di: Elif Y. Arı, et al.
Pubblicazione: (2025)

Application Value and Safety Analysis of Warfarin, Rivaroxaban, and Dabigatran Ester in Elderly Patients With Atrial Fibrillation
di: Cheng Chen, et al.
Pubblicazione: (2024)

Management of Antithrombotic Therapy in Patients With Coexisting Atrial Fibrillation and Coronary Artery Disease Who Underwent Percutaneous Coronary Intervention Within the Last Year
di: Sebastian König, et al.
Pubblicazione: (2025)

Atrial Fibrillation and Obstructive Sleep Apnea: Do Mortality Trends Reflect Disease Burden or Diagnostic Gaps?
di: Naoya Kataoka, et al.
Pubblicazione: (2025)

The Applicability of Novel Predictor of Intracranial Hemorrhage in Patients With Atrial Fibrillation in the Contemporary Real‐World Clinical Practice
di: Naoya Kataoka, et al.
Pubblicazione: (2025)

How to Demonstrate the Association Between the Inflammation and Atrial Fibrillation Recurrence
di: Naoya Kataoka, et al.
Pubblicazione: (2025)

Assessment of Risk Factors for Atrial Fibrillation With a Particular Focus on Echocardiographic Parameters, in Patients With Acute Myocardial Infarction
di: Beata Jacuś, et al.
Pubblicazione: (2025)

A Predictive Nomogram of In‐Hospital Mortality After 48 h for Atrial Fibrillation Patients in the Coronary Care Unit
di: Wenhui Wang, et al.
Pubblicazione: (2024)

Serum Urate and Atrial Fibrillation: A Bidirectional Mendelian Randomization Study
di: Shandong Yu, et al.
Pubblicazione: (2025)

How to Reduce the Incidence of Recurrence Following Catheter Ablation for Atrial Fibrillation
di: Naoya Kataoka, et al.
Pubblicazione: (2026)

The Relationship Between Ambulatory Arterial Stiffness Index and Incident Atrial Fibrillation
di: Christopher Boos
Pubblicazione: (2024)

The Effect of Age on 1‐Year Readmissions in Atrial Fibrillation Patients: Trends and Insights From a Conflict‐Stricken Country
di: Ibrahim Antoun, et al.
Pubblicazione: (2025)

Atrial Fibrillation Recurrence Risk After Catheter Ablation in Patients With Rheumatoid Arthritis: A Systematic Review and Meta‐Analysis
di: Pongprueth Rujirachun, et al.
Pubblicazione: (2025)

Incidence Rate and Predictors of Intracranial Hemorrhage in Patients With Atrial Fibrillation: A Report From the Nationwide COOL‐AF Registry
di: Rungroj Krittayaphong, et al.
Pubblicazione: (2024)

Association Between Hemoglobin Glycation Index and Mortality in Critically Ill Patients With Atrial Fibrillation: A Retrospective Cohort Study
di: Xianglin Long, et al.
Pubblicazione: (2026)

Enhancing Quality of Life in Symptomatic Paroxysmal Atrial Fibrillation Patients: A Systematic Analysis of Cognitive Behavioral Therapy Interventions
di: Pratik Agarwal, et al.
Pubblicazione: (2024)

Incremental Value of NT‐proBNP Over HCM‐AF Score in Risk Stratification for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy
di: Yi‐Peng Gao, et al.
Pubblicazione: (2026)

Questioning the Rhythm: A Closer Look at Heart Rate Trends in Atrial Fibrillation
di: Ibrahim Nagmeldin Hassan
Pubblicazione: (2025)

Trends in Mortality Due to Cardiovascular Diseases Among Patients With Parkinson's Disease in the United States: A Retrospective Analysis
di: Muzamil Akhtar, et al.
Pubblicazione: (2025)

Comment on “The Relationship Between Ambulatory Arterial Stiffness Index and Incident Atrial Fibrillation”
di: Mustafa Candemir, et al.
Pubblicazione: (2024)

Effect of Postoperative Atrial Fibrillation After Cardiac Surgery: A Meta‐Analysis
di: Fangzhou Qu, et al.
Pubblicazione: (2024)

Letter Regarding “Outcomes of Bolus Dose Furosemide Versus Continuous Infusion in Patients With Acute Decompensated Left Ventricular Failure and Atrial Fibrillation”
di: Ahmed M. Gazer, et al.
Pubblicazione: (2024)

How to Integrate Echocardiographic Risk Factors for Atrial Fibrillation Following Acute Myocardial Infarction
di: Naoya Kataoka, et al.
Pubblicazione: (2025)

RETRACTION: Vigorous Physical Activity and Atrial Fibrillation in Healthy Individuals: What Is the Correct Approach?
Pubblicazione: (2025)

Health Care Resource Utilization With Dronedarone Versus Sotalol Following Catheter Ablation in Adults With Atrial Fibrillation
di: Emily P. Zeitler, et al.
Pubblicazione: (2025)